This publication assembles the answers to many frequently asked questions concerning Drug Checking.

This Best practice portal section summarises evidence about the effect of the most widespread prevention interventions.

A report published by the NTA estimates that current drug treatment provision prevents 4.9 million crimes in England a year, with an estimated saving to society of £960 million in costs to the public, business, the criminal justice system and the NHS.

The Obama administration deserves credit for at least acknowledging the wasteful excesses of domestic drug enforcement and for taking steps to bolster treatment. But talk of a revolution in U.S. drug policy is still premature.

EHRN's report assesses the consequences of the sharp reduction in donor support that forced The Global Fund to halt new funding and to impose cost-cutting measures.

This report describes the illicit trade of opiates along the Northern route from northern Afghanistan to Central Asia up to the borders of the Russian Federation.

Naloxone should be made more widely available to tackle the high numbers of fatal opioid overdoses in the UK, according to a new report by the Advisory Council on the Misuse of Drugs (ACMD).

This report serves to: introduce the series by providing general conceptions of the global security challenges posed by violent armed groups; identify the issues of greatest import to scholars studying the phenomenon; and emphasize the need for the U.S. Government to understand variations in the...

The International HIV/AIDS Alliance warns of an impending HIV/AIDS crisis in Eastern Europe and Asia following its assessment of the impact of the cancelation of Global Fund Round 11 funding and is urging the Global Fund Board to revoke its ‘55% rule’ which limits funding for middle income,...

The Australian National Council on Drugs (ANCD) Asia Pacific Drug Issues Committee (APDIC) is pleased to announce the availability of translations of a new summary paper based on the influential 2nd Australian Needle and Syringe Program Return on Investment Study.

This is the second volume of Human Rights and Drugs, the official journal of the International Centre on Human Rights and Drug Policy. Articles in this volume address coerced drug treatment, the Convention on the Rights of the Child, the INCB and ayahuasca, and the death penalty for drug in...

At different points in history, drug production, use and supply have all been presented as threats to security whether human, national or international security.

This IDPC report is a detailed account of the main debates and events that took place at the 55th Session of the CND.

The meeting focused on the international drug control structures and the UN drug control conventions, the Austrian drug policy with special reference to young people who use drugs, and the work plan of the SEE Network for the coming year.

This is a year-long study of the current security situation on the U.S.-Mexico border and the impact of both countries' security policies on the migrant population.

Welcome to this treatment guide for HIV-positive people who also have hepatitis B (HBV). This guide provides information on the prevention, care, and treatment of HBV, and the impact of HBV on HIV disease. It is designed to be accessible to people with no medical training.

Across Europe information-only prevention approaches - despite a weak evidence for their effectiveness - continue to be most commonly used. Why this is the case is the question addressed by this editorial.

This report has been compiled by the EMCDDA in the first half of 2011 as a supporting document for the external evaluation of the 2005–12 EU drugs strategy and its two 2005–08 and 2009–12 action plans.

RAND Europe undertook an independent evaluation of the current 2005-2012 EU Drugs Strategy and its Action Plans, addressing four main research objectives.

Findings from international trials now suggest that the supervised use of medicinal heroin can be an effective second-line treatment for a small, and previously unresponsive, group. In this latest EMCDDA Insights report, experts describe the development as ‘an important clinical step forward’.